Heart Drug Could Treat Pre-Eclampsia
Posted on: Friday, 14 September 2007, 21:00 CDT
Texas researchers are testing the heart drug Digibind as a possible cure for pre-eclampsia.
Doctors at the University of Texas Medical Branch at Galveston say the heart drug, which has been around for more than 20 years, may delay delivery in expectant mothers with the life-threatening disorder.
Pre-eclampsia is the most common and dangerous pregnancy complication, affecting as many as eight in every 100 pregnant women.
Pre-eclampsia is the No. 1 killer of pregnant women in the world, and there is no cure except delivery, Dr. George Saade, chief of maternal-fetal medicine at UTMB, said Friday in a release.
The clinical trial will test whether Digibind reverses or prevents the abnormalities that occur with pre-eclampsia and allows the fetus to remain in the womb longer -- giving doctors more time to administer steroids to prevent respiratory complications in premature births.
Source: United Press International
Related Articles
- Protherics PLC Announces Research Update
- Protherics PLC Announces Research Update
- Protherics PLC Announces Patient Recruitment In Phase 2b "DEEP" Study In Severe Pre-Eclampsia Completed Ahead Of Schedule
- Bruker Daltonics and HealthLinx Expand Biomarker Discovery Collaboration
- Both mother's and father's genes can trigger pre-eclampsia
- Second-Trimester Sex Hormone-Binding Globulin and Subsequent Development of Pre-Eclampsia
- Babies at Risk As Mothers' Obesity Doubles
- Uterine Artery Doppler and Mid-Trimester Maternal Plasma Homocysteine in Subsequent Pre-Eclampsia
- Serum Leptin Levels and Uterine Doppler Flow Velocimetry at 20 Weeks' Gestation As Markers for the Development of Pre-Eclampsia
- Mind & Body; Pregnancy Pressure Almost Cost Me My Life
 |
 |
User Comments (0)
RSS Feeds